Results 231 to 240 of about 33,583 (261)
Some of the next articles are maybe not open access.

The Endocrine Heart: B-type Natriuretic Peptide as a Diagnostic and Therapeutic Agent in Cardiovascular Disease

The Endocrinologist, 2003
Since their discovery 20 years ago, natriuretic peptides have rapidly moved to the forefront in cardiovascular medicine, and have contributed to an appreciation that the heart is an important endocrine organ. Of the natriuretic peptides, brain (B-type) natriuretic peptide (BNP) has proven to be the most clinically useful.
Brian D. Le   +2 more
openaire   +1 more source

Role of cyclic GMP in the mechanism of action of nitrovasodilators, endothelium-dependent agents and atrial natriuretic peptide

Biochemical Society Transactions, 1988
The synthesis of cyclic GMP from GTP is catalysed by three isoenzyme forms of guanylate cyclase which include the soluble or cytosolic form, the particulate or membraneassociated form and a form associated with the cytoskeletal components (see reviews [ l , 21).
openaire   +2 more sources

TRIAMTERENE, A NEW NATRIURETIC AGENT

The American Journal of the Medical Sciences, 1963
P, BAUME, F J, RADCLIFF, J R, CORRY
openaire   +2 more sources

Lebetin 2, a Natriuretic-Like Peptide, as a Cardioprotective Agent: An in Silico Study

SSRN Electronic Journal, 2022
Hinda Allaoui   +4 more
openaire   +1 more source

The role of the natriuretic peptides in the cardiovascular system

Cardiovascular Research, 2001
Tsutomu Yamazaki   +2 more
exaly  

B-type natriuretic peptide in cardiovascular disease

Lancet, The, 2003
Nikolaus Marx   +2 more
exaly  

Home - About - Disclaimer - Privacy